Manifestations of gut opiate withdrawal contracture and its blockade by capsaicin.
D000818:Animals; D002211:Capsaicin / Q000494:pharmacology*; D004064:Digestive System / Q000503:physiopathology*; D004558:Electric Stimulation; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009197:Myenteric Plexus / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*
D005231:Fatty Acids, Unsaturated; D012702:Serotonin Antagonists; D012701:Serotonin; D013373:Substance P; D009270:Naloxone; D012601:Scopolamine; D002211:Capsaicin